SCHEMBL9926053

SCHEMBL9926053

COc1ccccc1N1CCN(C(=O)[C@@H]2CN(S(=O)(=O)c3cccs3)C[C@H]2c2ccccc2)CC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MC4R P32245 1/20 0.54
ALDH1A1 P00352 4/20 0.53
MAPT P10636 3/20 0.53
USP2 O75604 1/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2D6 P10635 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
KMT2A Q03164 2/20 0.51
TSHR P16473 2/20 0.50
GAA P10253 2/20 0.50
THRB P10828 1/20 0.50
POLB P06746 2/20 0.49
SMN1; SMN2 Q16637 4/20 0.49
HTT P42858 3/20 0.48
HTR1A P08908 1/20 0.48
ADRA1D P25100 1/20 0.48
ADRA1A P35348 1/20 0.48
ADRA1B P35368 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4840287 1.00 MC4R (0.54) MC4RALDH1A1MAPTUSP2CYP1A2
SCHEMBL9926057 0.91 SMN1; SMN2 (0.52) MC4RALDH1A1MAPTUSP2CYP1A2
SCHEMBL5341354 0.86 KMT2A (0.64) MC4RALDH1A1KMT2ATSHRGAA
SCHEMBL13987538 0.86 KMT2A (0.64) MC4RALDH1A1KMT2ATSHRGAA
SCHEMBL9926054 0.86 LMNA (0.53) ALDH1A1MAPTKMT2ATSHRTHRB
SCHEMBL9926051 0.86 SMN1; SMN2 (0.67) ALDH1A1MAPTCYP2C9CYP2C19SMN1; SMN2
SCHEMBL5264583 0.86 LMNA (0.53) ALDH1A1MAPTKMT2ATSHRTHRB
SCHEMBL9926111 0.85 MC4R (0.56) MC4RALDH1A1KMT2ATSHRGAA
SCHEMBL9926050 0.85 MC4R (0.51) MC4RALDH1A1MAPTKMT2ATSHR
SCHEMBL5266541 0.85 MC4R (0.51) MC4RALDH1A1MAPTKMT2ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1836180-B1 SULFONYL PYRROLIDINES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS DRUGS SANOFI SA (FR) 2012-06-13 EP disclosed
US-7468369-B2 Sulfonyl pyrrolidines, method for producing the same and their use as drugs SANOFI-AVENTIS (FR) 2008-12-23 US disclosed
US-7468369-B2 Sulfonyl pyrrolidines, method for producing the same and their use as drugs SANOFI-AVENTIS (FR) 2008-12-23 US disclosed
US-20080045540-A1 SULFONYL PYRROLIDINES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS DRUGS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-02-21 US disclosed
US-20080045540-A1 SULFONYL PYRROLIDINES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS DRUGS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045540-A1 SULFONYL PYRROLIDINES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS DRUGS SLC5A1, SLC5A2, KCNJ1 MC4R 1509/4885ALDH1A1 959/4885MAPT 4225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.